1. Corporate Officers - H
2. Hearne Michael S

Insider Trading History of Hearne Michael S

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Hearne Michael S since 2018. This trader's CIK number is 1759910. At the time of last reporting, Hearne Michael S was the Chief Financial Officer of La Jolla Pharmaceutical Co. (stock ticker symbol LJPC). Also see all insider trading activities at La Jolla Pharmaceutical Co.

Note that in the past Hearne Michael S also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at La Jolla Pharmaceutical Co (LJPC) by Hearne Michael S

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2021	LJPC	0	$0	441,290	$1,729,972	0	$0
2020	LJPC	1,325,145	$5,719,389	0	$0	0	$0

Yearly summary of insider trading at Odonate Therapeutics, Inc. (ODT) by Hearne Michael S

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2021	ODT	0	$0	2,747,131	$5,649,968	0	$0
2020	ODT	1,439,297	$20,636,151	0	$0	0	$0
2019	ODT	1,129,231	$28,255,084	0	$0	0	$0
2018	ODT	203,700	$2,795,347	0	$0	0	$0

Insider trading activities at 2 companies by Hearne Michael S:

1. La Jolla Pharmaceutical Co (LJPC)

2. Odonate Therapeutics, Inc. (ODT)

Table 1. Insider trading of La Jolla Pharmaceutical Co (LJPC) by Hearne Michael S

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2021-11-29	LJPC	Sale	193,403	4.10	793,145
2021-11-30	LJPC	Sale	70,342	3.95	277,780
2021-12-01	LJPC	Sale	177,545	3.71	659,047
2020-09-09	LJPC	Buy	126,665	4.02	509,699
2020-09-08	LJPC	Buy	84,152	3.90	328,529
2020-09-04	LJPC	Buy	67,552	3.83	258,386
2020-08-12	LJPC	Buy	43,513	3.47	150,816
2020-08-13	LJPC	Buy	219,465	3.65	800,608
2020-08-14	LJPC	Buy	168,669	3.88	653,761
2020-06-02	LJPC	Buy	253,553	4.88	1,237,085
2020-06-03	LJPC	Buy	145,764	4.90	714,826
2020-06-04	LJPC	Buy	215,812	4.94	1,065,679

Table 2. Insider trading of Odonate Therapeutics, Inc. (ODT) by Hearne Michael S

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2021-11-17	ODT	Sale	1,287,577	2.22	2,854,558
2021-11-18	ODT	Sale	1,094,265	1.92	2,095,517
2021-11-19	ODT	Sale	365,289	1.92	699,893
2020-12-21	ODT	Buy	62,144	14.57	905,748
2020-12-22	ODT	Buy	74,502	14.87	1,107,919
2020-12-23	ODT	Buy	139,138	15.57	2,166,100
2020-09-28	ODT	Buy	100,000	13.06	1,305,700
2020-09-29	ODT	Buy	10,882	13.85	150,693
2020-08-28	ODT	Buy	1,052,631	14.25	14,999,991
2019-06-26	ODT	Buy	769,231	26.00	20,000,006
2019-06-17	ODT	Buy	10,042	26.58	266,886
2019-06-18	ODT	Buy	21,350	26.89	574,016
2019-06-14	ODT	Buy	18,608	24.95	464,288
2019-06-06	ODT	Buy	56,308	27.74	1,561,871
2019-06-07	ODT	Buy	20,000	26.31	526,220
2019-06-03	ODT	Buy	15,286	22.51	344,057
2019-06-05	ODT	Buy	39,456	25.62	1,011,060
2019-06-04	ODT	Buy	38,950	24.95	971,880
2019-03-07	ODT	Buy	40,000	17.07	682,800
2019-03-08	ODT	Buy	100,000	18.52	1,852,000
2018-12-31	ODT	Buy	33,700	13.73	462,633
2018-12-28	ODT	Buy	20,000	12.69	253,860
2018-12-27	ODT	Buy	10,000	12.03	120,320
2018-12-20	ODT	Buy	10,000	13.17	131,740
2018-12-21	ODT	Buy	20,000	12.83	256,600
2018-12-26	ODT	Buy	30,000	12.28	368,280
2018-12-18	ODT	Buy	11,704	14.65	171,522
2018-12-17	ODT	Buy	18,296	14.85	271,768
2018-12-14	ODT	Buy	10,000	15.08	150,840
2018-12-11	ODT	Buy	5,450	15.25	83,128
2018-12-12	ODT	Buy	14,550	15.71	228,624
2018-12-07	ODT	Buy	9,500	14.98	142,291
2018-12-06	ODT	Buy	10,500	14.64	153,741

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hearne Michael S (Chief Financial Officer of La Jolla Pharmaceutical Co at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month